Cramer: I Choose Co...
Health Care: Drugs
Novo Nordisk A/S (NVO: NYSE)
$135.02 -0.19 | -0.14%
02/09/12 - 04:03 PM ET
239.06K / 268.50K
Vol / Avg. Vol:133.15 / 135.21
Open / Prev. Close:133.15 - 135.22
Today's Range:94.58 - 135.68
52 Wk Range:17.31%
Performance YTD:TheStreet Rating:
Portfolios with NVO
- Portfolio NameUser Type
- ContributorHighest-Yielding Drug Stocks
- ProRenaissance Technologies
- ProTom Gayner - Markel Gayner ...
- UserTEK Growth & Momentum
- UserD and B
- Contributor5 Blue-Chip Stocks to Buy
- UserPicks for 2011 (navalier)
- Userkimsh Rate Pension
- UserBesh
- UserAndras Alliance
Latest NVO Headlines from TheStreet
- Novo Nordisk A/S Stock Hits New 52-Week High (NVO) 02.07.12 | 10:02 am
- The Curse of Amylin's Diabetes Drug Approval 02.06.12 | 08:02 am
- 10 Sleazy Celebrity Endorsements 02.03.12 | 08:02 am
- Third Time's The Charm for Approval of Amylin Diabetes Drug 01.27.12 | 03:01 pm
- The 5 Dumbest Things on Wall Street: Jan. 20 01.20.12 | 06:01 am
- 5 Dumbest Things on Wall Street: Jan. 20
01.20.12 | 05:01 am - Novo Nordisk A/S (NVO): Today's Featured Drugs Winner 12.02.11 | 05:12 pm
- Novo Nordisk Sees Benefits From Lilly Breakup 11.18.11 | 05:11 am
- Novo Nordisk Sees Benefits From Lilly Breakup 11.18.11 | 05:11 am
- Novo Nordisk A/S (NVO): Today's Featured Drugs Winner 11.14.11 | 05:11 pm
Press Releases for NVO
- Novo Nordisk Partners With Paula Deen And Sons, Bobby And Jamie Deen, On National Diabetes Initiative - PR Newswire 01.17.12 | 05:01 am
- Walgreens And Novo Nordisk Team Up To Provide Free Complete Needle™ Collection & Disposal System For Patients Who Self-Inject - Business Wire 10.17.11 | 09:10 am
- Novo Nordisk Inc. Appoints Eddie Li As Vice President, Regulatory Affairs - PR Newswire 09.07.11 | 12:09 pm
- Novo Nordisk Partners With Minneapolis Community Groups To Support Diabetes Education Programs - PR Newswire 08.31.11 | 06:08 pm
- Novo Nordisk And Charlie Kimball Team Up To Challenge Diabetes Patients To Re-think How They Take Insulin - PR Newswire 03.24.11 | 07:03 am
- Ten States Bear Brunt Of Diabetes Burden - PR Newswire 03.17.11 | 08:03 am
- Novo Nordisk Creates First Mobile Application To Help Doctors Diagnose Bleeding Disorders - PR Newswire 02.04.11 | 09:02 am
- Novo Nordisk Makes FORTUNE's List Of '100 Best Companies To Work For' For Third Straight Year - PR Newswire 01.20.11 | 07:01 am
- Novo Nordisk Intends To Appeal Adverse Ruling In Prandin® (repaglinide) Patent Case - PR Newswire 01.19.11 | 07:01 pm
- Novo Nordisk Launches Customizable Online Resources For Managing Diabetes - PR Newswire 01.13.11 | 09:01 am
Partner Headlines for NVO
- Novo Nordisk Posts Solid 4Q - Analyst Blog - Zacks 02.06.12 | 10:02 am
- Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical - Seeking Alpha 01.13.12 | 09:01 am
- My Favorite Drug Stock - Seeking Alpha 12.21.11 | 08:12 am
- Bristol-Myers Presents Data - Analyst Blog - Zacks 12.09.11 | 07:12 pm
- The Long Case For Emisphere: Expecting A Buyout - Seeking Alpha 11.10.11 | 09:11 am
- 10 Heavily Sold Dividend Stocks With Impressive Profitability To Go Higher Again - Seeking Alpha 11.08.11 | 08:11 am
- Sanofi Set To Pass Pfizer As Biggest Drug Company - Seeking Alpha 11.06.11 | 09:11 am
- China Biotech Week In Review: Roche's China Strategy - Seeking Alpha 11.06.11 | 09:11 am
- 10 Overvalued Healthcare Stocks - Seeking Alpha 10.25.11 | 08:10 am
- Why Third Quarter Results Say Buy Small Companies Now (EMAN, PTEN, PDC, FXEN, GDXJ, NVO) - NASDAQ 10.14.11 | 06:10 pm
